Celgene needs to find new growth drivers beyond 2020, as its multiple myeloma blockbuster Revlimid is expected to see its sales growth slow in the coming years, even though its place as a backbone ...

NHS patients in England with newly-diagnosed multiple myeloma can be treated with Celgene’s Revlimid as maintenance therapy after a stem cell transplant, after new guidance from NICE.

the future of myeloma therapy will involve genotyping of individual patient tumors, and designing therapy based on the results. Therapy will become bespoke, targeting the multiple deregulated ...

“[Multiple myeloma] has not been considered curable ... a portfolio it scooped up in its $74 billion buyout of Celgene in 2019. It also markets Empliciti, a monoclonal antibody developed with AbbVie.

Breakthrough research and investor enthusiasm prompted Cullinan Therapeutics to redirect one of its cancer programs toward ...

We did separate analyses for lymphoma and multiple myeloma. In those with autoimmune or inflammatory ... CAJ has performed consultancy for Kite–Gilead, Novartis, Bristol Myers Squibb–Celgene, ADC ...

The PDUFA action date for an FDA decision for linvoseltamab to treat adult patients with relapsed/refractory multiple myeloma ...

Linvoseltamab is an investigational B-cell maturation antigen CD3-targeted bispecific antibody. The BLA resubmission was needed as the original application could not be approved due to manufacturing ...

Researchers sought to determine whether teclistamab would lead to a clinical response in patients with relapsed/refractory multiple myeloma.

Researchers sought to identify prognostic factors for survival in patients with newly diagnosed multiple myeloma.

Regeneron, which is seeking FDA approval of linvoseltamab for adults with relapsed/refractory multiple myeloma that has progressed after at least three prior therapies, said the agency set a new ...

Firefighters, police officer who responded to 9/11 in World Trade Center do have an increased risk of multiple myeloma. There are some other well-defined occupational exposures. For instance ...